1)岡部治弥,崎村正弘.仮称非特異性多発性小腸潰瘍症.胃と腸 3:1539-1549, 1968
2)八尾恒良,淵上忠彦,崎村正弘,他.腸の潰瘍性病変に関する新しい提案─所謂“非特異性多発性小腸潰瘍症”を中心として.胃と腸 7:1615-1619, 1972
3)Umeno J, Hisamatsu T, Esaki M, et al. A hereditary enteropathy caused by mutations in the SLCO2A1 gene, encoding a prostaglandin transporter. PLoS Genet 11:e1005581, 2015
4)日本医療研究開発機構委託研究開発費(難治性疾患実用化研究事業)「難治性小腸潰瘍の診断法確立と病態解明に基づいた治療法探索」研究班.非特異性多発性小腸潰瘍症画像診断アトラス,2016
5)Hosoe N, Omiya N, Hirai F, et al. Chronic enteropathy associated with SLCO2A1 gene(CEAS)-Characterization of an enteric disorder to be considered in the differential diagnosis of Crohn's disease. J Crohns Colitis, 2017[Epub ahead of print]
6)Esaki M, Umeno J, Kitazono T, et al. Clinicopathologic features of chronic nonspecific multiple ulcers of the small intestine. Clin J Gastroenterol 8:57-62, 2015
7)Matsumoto T, Nakamura S, Esaki M, et al. Endoscopic features of chronic nonspecific multiple ulcers of the small intestine:comparison with nonsteroidal anti-inflammatory drug-induced enteropathy. Dig Dis Sci 51:1357-1363, 2006
8)細江直樹,久松理一.非特異性多発性小腸潰瘍症(chronic enteropathy associated with SLCO2A1 ; CEAS).胃と腸 51:1724-1726, 2016